Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 493.65
-1.70 (-0.34%)
Jul 16, 2025, 3:29 PM IST
NSE:INDRAMEDCO Revenue
In the fiscal year ending March 31, 2025, Indraprastha Medical Corporation had annual revenue of 13.56B INR with 8.97% growth. Indraprastha Medical Corporation had revenue of 3.34B in the quarter ending March 31, 2025, with 6.04% growth.
Revenue
13.56B
Revenue Growth
+8.97%
P/S Ratio
3.35
Revenue / Employee
4.56M
Employees
2,977
Market Cap
45.41B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Mankind Pharma | 122.07B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Glenmark Pharmaceuticals | 134.35B |